Compare Graham Holdings Company Common Stock (GHC) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Graham Holdings Company Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Graham Holdings Company Common Stock trades at $1,190.11 (market cap $4.97B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Graham Holdings Company Common Stock is far larger — about 3.4× uniQure N.V. Ordinary Shares's market cap, and Graham Holdings Company Common Stock pays a 0.64% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| GHC | QURE | |
|---|---|---|
Market Cap | $4.97B | $1.48B |
Volume | 27,383 | 2,488,780 |
Sector | Industrials | Health |
52-Week High | $1.23K | $70.59 |
52-Week Low | $949.84 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.06B | $728.62M |
Dividend Yield | 0.64% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Graham Holdings Company Common Stock
Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.
Read more on GHC →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
